Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug

investors.com/news/technology/biohaven-stock-delay-troriluzole-sca/?src=A00220

This story appeared on investors.com, 2025-05-15 13:22:52.
The Entire Business World on a Single Page. Free to Use →